WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.57 Billion CNY | 13.18% |
| 2022 | 14.67 Billion CNY | 76.62% |
| 2021 | 8.31 Billion CNY | 32.28% |
| 2020 | 6.28 Billion CNY | 25.29% |
| 2019 | 5.01 Billion CNY | 32.2% |
| 2018 | 3.79 Billion CNY | 16.75% |
| 2017 | 3.24 Billion CNY | 30.31% |
| 2016 | 2.49 Billion CNY | 47.75% |
| 2015 | 1.68 Billion CNY | 10.81% |
| 2014 | 1.52 Billion CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.04 Billion CNY | -31.02% |
| 2024 Q3 | 4.47 Billion CNY | 19.54% |
| 2024 Q2 | 3.74 Billion CNY | 23.0% |
| 2023 Q2 | 4.06 Billion CNY | 13.82% |
| 2023 FY | 16.61 Billion CNY | 13.18% |
| 2023 Q1 | 3.57 Billion CNY | -13.56% |
| 2023 Q3 | 4.55 Billion CNY | 11.9% |
| 2023 Q4 | 4.41 Billion CNY | -3.12% |
| 2022 Q3 | 4.1 Billion CNY | 20.56% |
| 2022 Q1 | 3.03 Billion CNY | 37.9% |
| 2022 FY | 14.67 Billion CNY | 76.62% |
| 2022 Q2 | 3.4 Billion CNY | 12.22% |
| 2022 Q4 | 4.13 Billion CNY | 0.8% |
| 2021 FY | 8.31 Billion CNY | 32.28% |
| 2021 Q4 | 2.19 Billion CNY | -0.62% |
| 2021 Q2 | 2.06 Billion CNY | 12.2% |
| 2021 Q1 | 1.83 Billion CNY | -0.3% |
| 2021 Q3 | 2.21 Billion CNY | 7.41% |
| 2020 Q2 | 1.56 Billion CNY | 42.93% |
| 2020 Q1 | 1.09 Billion CNY | -18.52% |
| 2020 Q3 | 1.77 Billion CNY | 12.84% |
| 2020 FY | 6.28 Billion CNY | 25.29% |
| 2020 Q4 | 1.84 Billion CNY | 3.98% |
| 2019 Q4 | 1.34 Billion CNY | -2.29% |
| 2019 Q2 | 1.22 Billion CNY | 16.44% |
| 2019 Q1 | 1.05 Billion CNY | 8.1% |
| 2019 FY | 5.01 Billion CNY | 32.2% |
| 2019 Q3 | 1.37 Billion CNY | 12.19% |
| 2018 Q1 | 837.47 Million CNY | 2.03% |
| 2018 FY | 3.79 Billion CNY | 16.75% |
| 2018 Q2 | 929.05 Million CNY | 10.94% |
| 2018 Q4 | 977.08 Million CNY | -6.86% |
| 2018 Q3 | 1.04 Billion CNY | 12.92% |
| 2017 FY | 3.24 Billion CNY | 30.31% |
| 2017 Q4 | 820.8 Million CNY | -1.98% |
| 2017 Q3 | 837.39 Million CNY | 2.33% |
| 2017 Q1 | 771.95 Million CNY | 0.0% |
| 2017 Q2 | 818.31 Million CNY | 6.01% |
| 2016 FY | 2.49 Billion CNY | 47.75% |
| 2015 FY | 1.68 Billion CNY | 10.81% |
| 2014 FY | 1.52 Billion CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 8588179.788% |
| Arrayit Corporation | 2.57 Million USD | -643574.589% |
| Atlantic International Corp. | -154.23 Thousand USD | 10746753.779% |
| Biocept, Inc. | -2.58 Million USD | 642043.997% |
| Bioqual, Inc. | 7.42 Million USD | -223008.053% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -6005332.605% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | -145.922% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -923768.42% |
| iMD Companies, Inc. | -23.63 Thousand USD | 70123186.644% |
| IDenta Corp. | 662.97 Thousand USD | -2499993.366% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -71830.712% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -21367413.62% |
| InVitro International | 635.98 Thousand USD | -2606092.597% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -252452.095% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -1516806.442% |
| NovelStem International Corp. | 12 Thousand USD | -138124849.917% |
| Optigenex Inc. | -102.96 Thousand USD | 16097640.926% |
| PharmChem, Inc. | 3.9 Million USD | -424423.509% |
| Proteome Sciences plc | 2.09 Million USD | -790453.702% |
| Response Genetics, Inc | 3.94 Million USD | -420371.689% |
| Rennova Health, Inc. | 6.26 Million USD | -264327.733% |
| RushNet, Inc. | 1.1 Million USD | -1500422.263% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -1934933.516% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 4105392.173% |
| Todos Medical Ltd. | 4.31 Million USD | -384470.626% |